BioAge Labs, Inc. ( (BIOA) ) has released its Q3 earnings. Here is a breakdown of the information BioAge Labs, Inc. presented ...

BioAge Labs, Inc. ( (BIOA)) has released its Q3 earnings. Here is a breakdown of the information BioAge Labs, Inc. presented to its investors. BioAge Labs, Inc. is a clinical-stage biotechnology ...

Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.

RICHMOND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases ...

Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable private ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

BioAge Labs Inc (NASDAQ: BIOA)’s stock price has dropped by -11.78 in relation to previous closing price of 22.67. Nevertheless, the company has seen a loss of -8.80% in its stock price over the last ...

The two leaders will meet in Peru, where China has steadily expanded its influence in a challenge to the United States in its own region. By David Pierson and Mitra Taj Displaced young ...

Facing China, Trump to be “direct” in dealings with Africa Cameron Hudson talks about how Trump’s approach to competing with China in Africa will dramatically differ from Biden’s.